Revenue segments as reported by the company.

Instruments & Accessories

Systems

Services

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Intuitive Surgical

Intuitive Surgical, Inc. engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Intuitive Surgical reports robust Q4 performance and eyes future growth

Intuitive Surgical's Q4 2022 showcased strong performance and growth in procedures and system placements.
While facing challenges like macroeconomic uncertainty and supply chain costs, the company is poised for continued innovation.
Opportunities lie in expanding markets, advancing technology, and improving surgical outcomes through collaboration.
Investments in industrial scale, automation, and platform advancements signal a strategic focus on future growth.

Intuitive Surgical (ISRG) reports robust Q1 performance and growth outlook

Intuitive Surgical (ISRG) delivered strong Q1 results with revenue up 14% and exceeding procedure growth expectations.
While facing challenges in manufacturing and supply chain, the company is focusing on R&D progress and inventory replenishment.
The outlook for 2023 looks promising with increased procedure growth forecasts and a focus on improving patient outcomes and market expansion.
Overall, Intuitive Surgical (ISRG) is well-positioned to capitalize on opportunities for growth and innovation in the robotic surgery market.

Intuitive Surgical excels in Q2 performance, eyes AI opportunities

Intuitive Surgical's Q2 2023 performance showcased strong revenue growth, procedure increases, and a focus on healthcare improvement.
The company's strengths include innovative ecosystem investments, commitment to patient outcomes, and advanced surgical technologies.
Challenges include market disruptions from new drugs, expense management, and adapting to changing healthcare landscapes.
Opportunities in AI, market expansion, and new procedures position Intuitive Surgical for continued growth and innovation.

Intuitive Surgical excels in Q3, eyes global expansion and margin growth

Intuitive Surgical's Q3 performance reflects strong growth and strategic focus on innovation and market expansion. Despite challenges in specific procedure categories and pricing dynamics, the company is well-positioned to capitalize on opportunities for growth and margin improvement.

Intuitive Surgical posts strong 2023 results, da Vinci 5 launch ahead

Intuitive Surgical's 2023 performance reflects strong revenue growth, operational excellence, and a strategic focus on innovation with the upcoming da Vinci 5 launch.
While facing challenges in operating margin pressure and supply chain issues, the company is well-positioned to capitalize on opportunities in soft tissue surgery, big data integration, and leased placements.
Investors should monitor how Intuitive Surgical navigates the launch of da Vinci 5, manages operational challenges, and leverages growth opportunities to sustain its market leadership.
Overall, Intuitive Surgical's Q4 earnings call highlights a resilient business model, customer-centric approach, and a commitment to advancing surgical technology for better patient outcomes.

Intuitive Surgical posts robust Q1 results amidst global market challenges

Intuitive Surgical delivered strong Q1 results with notable procedure and revenue growth, despite challenges in certain markets.
The company's focus on newer platforms, operational efficiency, and strategic outlook for 2024 positions it for continued success.
Addressing challenges and seizing opportunities in global markets and product innovation will be key for sustained growth and competitiveness.

Intuitive Surgical excels in Q2, eyes global expansion and innovation

Intuitive Surgical's Q2 performance reflects strength in procedure growth and system platform advancements.
The company's commitment to innovation and value creation positions them well for future success.
Challenges include sustaining margins and navigating market dynamics, while opportunities lie in expansion and innovation.
Overall, Intuitive Surgical's focus on growth, technology, and patient care sets a positive trajectory for the future.

Intuitive Surgical excels in Q3 with strong growth and innovation

Intuitive Surgical's Q3 2024 performance reflects a company in a strong position with notable achievements in procedures, financials, and technological advancements. While facing challenges in margin progression and international expansion, the company is well-positioned to leverage opportunities in innovation and customer insights.

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

DaVita

HCA Healthcare

The healthcare industry is one of the biggest in the United States and other countries. In the US, the total Medicare expenditure stood at over $927 billion in 2022 and the trend is continuing as the population ages.

Best blue chip healthcare stocks to buy and hold in 2024

Intuitive Surgical Intuitive Surgical (NASDAQ NASDAQ : ISRG) recently reported its Q1 results, with revenues and earnings beating the street estimates. The company reported revenue of $1.89 billion and adjusted earnings of $1.50 per share, compared to the consensus estimates of $1.87 billion and $1.41, respectively.

Should You Pick Intuitive Surgical Stock At $370?

While artificial intelligence (AI) and robots are in the spotlight regularly these days, there's a company that's been making surgical robots for over two decades. Intuitive Surgical Inc. NASDAQ: ISRG is the pioneer in robotic-assisted surgical systems.

Intuitive Surgical Leads the Robotic Surgery Movement

Intuitive Surgical outperformed analyst expectations for both EPS and revenue for Q1. Regulatory approvals for da Vinci 5 and a single-port surgical system set the stage for expansion.

Intuitive Surgical's Q1 Earnings: A Robotic Surge

If you wonder if Intuitive Surgical NASDAQ: ISRG stock can trend higher this year, it can. The med tech business is growing, and Intuitive Surgical is the industry leader and outperforming expectations.

Intuitive Surgical Stock Can Trend Much Higher This Year

Intuitive Surgical's (ISRG) first-quarter results reflect a healthy demand for procedures. Higher pricing boosts procedure sales.

Intuitive Surgical (ISRG) Q1 Earnings Beat, Procedures Robust

Bristol-Myers

Novo Nordisk

Healthcare stocks can be excellent choices for investors, offering a balance of safety and growth. Intuitive Surgical, Bristol Myers Squibb, and Novo Nordisk all have strong growth potential.

Got $500? 3 Healthcare Stocks to Buy and Hold Forever

Shares in Intuitive Surgical (ISRG) jumped more than 3% in after-hours Thursday after surpassing analysts' earnings and revenue forecasts amid growing demand for the company's robotics solutions used in minimally invasive medical procedures.

Intuitive Surgical Stock Jumps After Q1 Earnings Beat Amid da Vinci Robotic System Growth

Intuitive Surgical, Inc. (NASDAQ:ISRG ) Q1 2024 Earnings Conference Call April 18, 2024 4:30 PM ET Company Participants Brian King - Head of Investor Relations Gary Guthart - Chief Executive Officer Jamie Samath - Chief Financial Officer Conference Call Participants Robbie Marcus - JPMorgan Larry Biegelsen - Wells Fargo Travis Steed - Bank of America Rick Wise - Stifel Adam Maeder - Piper Sandler Drew Ranieri - Morgan Stanley Matt Miksic - Barclays Brandon Vazquez - William Blair Jayson Bedford - Raymond James Operator Thank you everyone for standing by and welcome to the Intuitive Q1 2024 Earnings Release Call. At this time, all participants are on a listen-only mode.

Intuitive Surgical, Inc. (ISRG) Q1 2024 Earnings Call Transcript

The headline numbers for Intuitive Surgical (ISRG) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Intuitive Surgical (ISRG) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

Netflix

Taiwan Semiconductor Manufacturing

Netflix, Taiwan Semi and Intuitive Surgical all handily beat Q1 estimates, but only one is trading in the green this afternoon.

Big Q1 Beats After the Close; Markets Struggle to Gain

Intuitive Surgical, Inc. (ISRG) came out with quarterly earnings of $1.50 per share, beating the Zacks Consensus Estimate of $1.40 per share. This compares to earnings of $1.23 per share a year ago.

Intuitive Surgical, Inc. (ISRG) Q1 Earnings and Revenues Top Estimates

Intuitive Surgical beat Wall Street estimates for first-quarter profit and revenue on Thursday, riding on higher demand for its robots used in minimally invasive procedures.

Medical device maker Intuitive beats estimates on strong demand for surgical robots

Intuitive Surgical stock was muted late Thursday after the robotic surgery company beat first-quarter expectations.

Intuitive Surgical Narrowly Beats First-Quarter Expectations, But Shares Remain Muted

SUNNYVALE, Calif., April 18, 2024 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended March 31, 2024.

Intuitive Announces First Quarter Earnings

The earnings slate is set to heat up in the coming days.

Big-Picture Investing as Q1 Earnings Loom: Stocks to Watch

ABB Ltd

iRobot

Robotics stocks offer a high-potential frontier, considering the market is expected to grow over 11% between 2024 to 2028. It's anticipated to eventually land on a total market volume of over $65 billion.

Robotics Stocks to Watch in April: 3 Top Picks Poised for Explosive Growth

Intuitive Surgical (ISRG) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Should You Buy Intuitive Surgical (ISRG) Ahead of Earnings?

Equifax

Elevance Health Inc

We have narrowed our search to five large-cap stocks that are poised to beat on earnings results this week. These are: NFLX, ISRG, ELV, EFX, CSX.

5 Giants Likely to Win Big on Earnings Results This Week

Intuitive Surgical's (NASDAQ: ISRG) stock price will be in the spotlight this week as the company publishes its financial results on Thursday. These results will come at a time when its recent rally has stalled.

Intuitive Surgical (ISRG) stock price forecast and earnings preview

Intuitive Surgical's (ISRG) first-quarter results are likely to reflect solid performance in the Instruments & Accessories segment. However, rising costs might have hurt margins.

Is a Beat Likely for Intuitive Surgical (ISRG) in Q1 Earnings?

Intuitive Surgical is set to report Q1 earnings later this week, and the company has previously outperformed with substantial revenue and EPS beats. The company leads in robotic surgery with high service revenue and margins; da Vinci 5 launch is anticipated next year. Financially robust, Intuitive Surgical shows strong cash reserves and operating cash flow, maintaining a healthy balance sheet.

Intuitive Surgical Readies For Robotic Resurgence In Upcoming Earnings

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Intuitive Surgical (ISRG), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2024.

Intuitive Surgical (ISRG) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates

AbbVie

Exxon Mobil

If you want to invest in some new halal stocks, you know that finding companies compliant with Shariah law can be complicated.

These four halal, Shariah-compliant stocks are best buys after Eid al-Fitr

Hitachi Ltd

Symbotic Inc

While robotics has been transforming major industrial spaces for decades, the rise of artificial intelligence (AI) could create even more efficiencies in this burgeoning field. In particular, with the advent of novel AI technologies, robotics could enter a new era of growth.

News for Intuitive Surgical Stock (ISRG)